Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal Sees Limited Risk From Kmart Bankruptcy

Executive Summary

Cardinal's inventory consignment agreement with Kmart limits the drug wholesaler's financial exposure from the retailer's bankruptcy, Cardinal CEO Robert Walter told a Jan. 22 earnings call

You may also be interested in...



Cardinal Manufactures 10% Gain In 1Q: Rx Stocks Stay Out Of Favor

Cardinal's expanding manufacturing capacity is enhancing its image with investors who are attracted to the pharmaceutical sector but wary of the risks of drug development

Cardinal Manufactures 10% Gain In 1Q: Rx Stocks Stay Out Of Favor

Cardinal's expanding manufacturing capacity is enhancing its image with investors who are attracted to the pharmaceutical sector but wary of the risks of drug development

Cardinal Expects New Drug Manufacturing Acquisition In December

Cardinal Health expects to announce the acquisition of another pharmaceutical manufacturing plant by the end of December, Chief Operating Officer John Kane told an analysts' meeting Nov. 6-7 in Tampa, Fla.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel